ArticlePharmaceutics2022
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [
Koen Vermeulen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticlePharmaceutics2022
Koen Vermeulen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.